Anticancer potential of osthole: targeting gynecological tumors and breast cancer
Pharmacological Reports · 2025
DOI: 10.1007/s43440-024-00685-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Reports, 2025. Verfasst von Yingqi Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Lixia District, Jinan, Shangdong Provinc…. Hauptthemen laut MEDLINE: Coumarins, Breast Neoplasms, Genital Neoplasms, Female, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: National Key Research and Development Program Funding Project.
Abstract (Originalsprache)
Gynecological tumors, such as ovarian, endometrial, and cervical cancers, alongside breast cancer, represent significant malignancies that pose serious threats to women's health worldwide. Standard treatments, including surgery, chemotherapy, radiotherapy, and targeted therapies, are commonly utilized in clinical practice. However, challenges such as high recurrence rates, drug resistance, and adverse side effects underscore the urgent need for more effective therapeutic options. Osthole, a natural coumarin compound derived from Chinese herbal medicine, has demonstrated remarkable antitumor activity against various cancers. Emerging evidence indicates that osthole can inhibit the proliferation, invasion, and metastasis of gynecological and breast cancer cells through various mechanisms, including inducing apoptosis and autophagy, regulating the tumor microenvironment, inhibiting tumor angiogenesis, and enhancing the sensitivity of cancer cells to chemotherapy and radiotherapy. This review highlights the recent advancements in osthole research within the context of gynecological and breast cancers, focusing on its molecular mechanisms, and offers a theoretical foundation for its potential development as an anticancer agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Lixia District, Jinan, Shangdong Province, 250014, China.
- Department of Reproduction and Genetics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, Shangdong Province, 250014, China. sunzhengao77@126.com.
Förderung
- National Key Research and Development Program Funding Project
Zitieren
APA
Han, Y., & Sun, Z. (2025). Anticancer potential of osthole: targeting gynecological tumors and breast cancer. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00685-3
Vancouver
Han Y, Sun Z. Anticancer potential of osthole: targeting gynecological tumors and breast cancer. Pharmacological Reports. 2025. doi:10.1007/s43440-024-00685-3
BibTeX
@article{Han2025,
author = {Han, Yingqi and Sun, Zhengao},
title = {Anticancer potential of osthole: targeting gynecological tumors and breast cancer},
journal = {Pharmacological Reports},
year = {2025},
doi = {10.1007/s43440-024-00685-3}
}
EUVIMED